Treatment to Quit Smoking

Completed · Phase 2

Conditions studied: Smoking

In brief

This protocol evaluates the efficacy of combining pharmacologic treatments for smoking cessation, entailing the use of the nicotine skin patch with the nicotinic antagonist mecamylamine, with a specific behavioral therapy designed to inhibit the smoking urge.

Key facts

Study ID

NCT00018161

Run by

US Department of Veterans Affairs

Starts

1997-01-01

Expected to finish

2001-06-01

Last updated by the study team

2009-01-21

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Veterans Affairs Medical Center — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.